Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in Focus - Dalal Street Investment Journal
Nifty 50, Sensex May Open Muted Ahead of RBI Policy; Titan, Aurobindo Pharma, Groww in FocusDalal Street Investment Journal
J B Chemicals & Pharmaceuticals Ltd rises for third consecutive session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2243.5, up 2.32% on the day as on 12:49 IST on the NSE. The stock is up 31.82% in last one year as compared to a 4.24% spurt in NIFTY and a 14.46% spurt in the Nifty Pharma index.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
J B Chemicals & Pharmaceuticals Ltd spurts 0.08%, gains for fifth straight session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2144.9, up 0.08% on the day as on 12:44 IST on the NSE. The stock is up 40.69% in last one year as compared to a 0.65% jump in NIFTY and a 14.52% jump in the Nifty Pharma.
J B Chemicals & Pharmaceuticals Ltd up for third straight session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2141, up 2.22% on the day as on 12:49 IST on the NSE. The stock is up 39.32% in last one year as compared to a 1.62% jump in NIFTY and a 12.19% jump in the Nifty Pharma index.

Nippon India Mutual Fund raises stake in this healthcare stock. Do you own? - Mint
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own?Mint

Buy or sell: Gift Nifty signals gap-up opening, Vaishali Parekh recommends three stocks to buy today — 4 May 2026
Buy or sell: Gift Nifty up, Vaishali Parekh recommends three stocks to buy today — Thirumalai Chemicals, CESC, and Bharat Dynamics
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.